These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 6718336)
21. Oligofructose does not affect the development of type 1 diabetes mellitus induced by dietary proteins in the diabetes-prone BB rat model. Perrin IV; Marchesini M; Rochat FC; Schiffrin EJ; Schilter B Diabetes Nutr Metab; 2003 Apr; 16(2):94-101. PubMed ID: 12846448 [TBL] [Abstract][Full Text] [Related]
22. [Lipid metabolism disorders in white rats following depression of the anticlotting system by an atherogenic diet]. Bazaz'ian GG; Levchuk TP; Zolotova TA; Liapina LA; Sytina NP Vopr Pitan; 1977; (2):20-5. PubMed ID: 898819 [TBL] [Abstract][Full Text] [Related]
23. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat. Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945 [TBL] [Abstract][Full Text] [Related]
24. [Role of the diabetogenic factor in the activation of the blood coagulation system in experimental alloxan diabetes]. Kudriashov BA; Ul'ianov AM; Liapina LA Patol Fiziol Eksp Ter; 1986; (4):44-7. PubMed ID: 3797076 [No Abstract] [Full Text] [Related]
25. The effect of atherogenic diet and experimental alloxan-induced diabetes on serum levels of proteins, glucose, and lipids in rabbits. Lopatyński J; Tomaszewski J; Wolański I; Hanzlik J; Zawiślak H; Kozak J Acta Physiol Pol; 1974; 25(6):547-51. PubMed ID: 4456967 [No Abstract] [Full Text] [Related]
26. [Thrombocyte aggregation in depression of the function of the anticoagulation system of blood, caused by atherogenic diet]. Bazazian GG; Pastorova VE; Liapina LA Kardiologiia; 1976 May; 16(5):139-41. PubMed ID: 950749 [No Abstract] [Full Text] [Related]
27. [Epileptic seizures in experimental atherosclerosis]. Iakhin FA; Bazaz'ian GG; Sytina NP Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):871-6. PubMed ID: 7415709 [TBL] [Abstract][Full Text] [Related]
28. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation]. Shorin IuP; Seliatitskaia VG; Nepomniashchikh GI; Pal'chikova NA; Khodova RR Biull Eksp Biol Med; 1984 Aug; 98(8):240-2. PubMed ID: 6466864 [TBL] [Abstract][Full Text] [Related]
29. Cameroon local diet-induced glucose intolerance and dyslipidemia in adult Wistar rat. Kamgang R; Mboumi RY; N'dillé GP; Yonkeu JN Diabetes Res Clin Pract; 2005 Sep; 69(3):224-30. PubMed ID: 16098918 [TBL] [Abstract][Full Text] [Related]
30. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse. Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265 [TBL] [Abstract][Full Text] [Related]
31. [Stable reduction of endogenous insulin production in the body in experimental insulin-dependent diabetes]. Kudriashov BA; Ul'ianov AM Vopr Med Khim; 1991; 37(4):40-3. PubMed ID: 1750208 [TBL] [Abstract][Full Text] [Related]
32. [Delay in thrombin clearance as a diagnostic test of prethrombosis in depression of the anticoagulation system caused by atherogenic diet]. Kudriashov BA; Bagaz'ian GG; Ul'ianov AM; Liapina LA; Sytina NP Vopr Med Khim; 1976; 22(6):736-40. PubMed ID: 1027248 [TBL] [Abstract][Full Text] [Related]
33. [Antithrombin III activity in long-developing hypercoagulation in animals]. Pastorova VE; Bazaz'ian GG; Liapina LA Biull Eksp Biol Med; 1984 Nov; 98(11):560-3. PubMed ID: 6509173 [TBL] [Abstract][Full Text] [Related]
34. [Quantitative evaluation of the sensitivity of experimental animals to the diabetogenic effect of alloxan]. Pal'chikova NA; Seliatitskaia VG; Shorin IuP Probl Endokrinol (Mosk); 1987; 33(4):65-8. PubMed ID: 3658953 [TBL] [Abstract][Full Text] [Related]
35. Relationship of stressful housing conditions to the onset of diabetes mellitus induced by multiple, sub-diabetogenic doses of streptozotocin in mice. Mazelis AG; Albert D; Crisa C; Fiore H; Parasaram D; Franklin B; Ginsberg-Fellner F; McEvoy RC Diabetes Res; 1987 Dec; 6(4):195-200. PubMed ID: 2966026 [TBL] [Abstract][Full Text] [Related]
36. [The toxic action of the "diabetogenic factor" metabolite in the body during the development of insulin-dependent diabetes]. Kudriashov BA Izv Akad Nauk Ser Biol; 1993; (5):694-702. PubMed ID: 8220079 [TBL] [Abstract][Full Text] [Related]
37. [An analysis of the mechanisms of depression of the blood's anticoagulating system]. Kudriashov BA; Bazaz'ian GG; Ulianov AM; Liapina LA; Sytina NP Fiziol Zh SSSR Im I M Sechenova; 1975 Sep; 61(9):1402-7. PubMed ID: 1213204 [TBL] [Abstract][Full Text] [Related]
38. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893 [TBL] [Abstract][Full Text] [Related]
40. Age-dependent changes in the sensitivity of the rat to a diabetogenic agent (streptozotocin). Masiello P; De Paoli A; Bergamini E Endocrinology; 1975 Mar; 96(3):787-9. PubMed ID: 123196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]